Identifying "at-risk" patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections

被引：16
作者：
Abdul-Aziz, Mohd H. [1 ,2 ]
Lipman, Jeffrey [1 ,3 ]
Roberts, Jason A. [1 ,3 ,4 ,5 ]
机构：
[1] Univ Queensland, Ctr Clin Res UQCCR, Fac Med, Royal Brisbane & Womens Hosp, Bldg 71-918, Brisbane, Qld 4029, Australia
[2] Int Islamic Univ Malaysia, Sch Pharm, Kuantan, Malaysia
[3] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
[4] Univ Queensland, Sch Pharm, Ctr Translat Antiinfect Pharmacodynam, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia
来源：
CRITICAL CARE | 2017年 / 21卷
基金：
英国医学研究理事会;
关键词：
Augmented renal clearance; Critically ill; Meropenem; Pharmacokinetic; Pharmacodynamic; Risk assessment tool; MEROPENEM;
D O I：
10.1186/s13054-017-1871-2
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
[1]   Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections [J].
Mohd H. Abdul-Aziz ;
Jeffrey Lipman ;
Jason A. Roberts .
Critical Care, 21
[2]   Continuous beta-lactam infusion in critically ill patients: the clinical evidence [J].
Abdul-Aziz, Mohd H. ;
Dulhunty, Joel M. ;
Bellomo, Rinaldo ;
Lipman, Jeffrey ;
Roberts, Jason A. .
ANNALS OF INTENSIVE CARE, 2012, 2
[3]   Continuous beta-lactam infusion in critically ill patients: the clinical evidence [J].
Mohd H Abdul-Aziz ;
Joel M Dulhunty ;
Rinaldo Bellomo ;
Jeffrey Lipman ;
Jason A Roberts .
Annals of Intensive Care, 2
[4]   Beta-lactam antibiotics in continuous infusion in critically ill patients [J].
Axel Jeurissen ;
Robert Rutsaert .
Critical Care, 14
[5]   Beta-lactam antibiotics in continuous infusion in critically ill patients [J].
Jeurissen, Axel ;
Rutsaert, Robert .
CRITICAL CARE, 2010, 14 (05)
[6]   Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients [J].
Sulaiman, Helmi ;
Roberts, Jason A. ;
Abdul-Aziz, Mohd H. .
FARMACIA HOSPITALARIA, 2022, 46 (03) :182-190
[7]   The higher the better? Defining the optimal beta-lactam target for critically ill patients to reach infection resolution and improve outcome [J].
Scharf, Christina ;
Liebchen, Uwe ;
Paal, Michael ;
Taubert, Max ;
Vogeser, Michael ;
Irlbeck, Michael ;
Zoller, Michael ;
Schroeder, Ines .
JOURNAL OF INTENSIVE CARE, 2020, 8 (01)
[8]   Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: implementation considerations [J].
Barton, Greg ;
Rickard, Claire M. ;
Roberts, Jason A. .
INTENSIVE CARE MEDICINE, 2024, 50 (12) :2150-2153
[9]   Beta-Lactam Antibiotic Concentrations and the Acquisition of Multi-Drug Resistant Bacteria in Critically Ill Patients [J].
Farinella, Anita ;
Salvagno, Michele ;
Minini, Andrea ;
Attanasio, Laila ;
Cunha, Ana ;
Menozzi, Marco ;
Saravia, Andres ;
Amado, Filipe ;
Gorham, Julie ;
Hites, Maya ;
Taccone, Fabio Silvio ;
Bogossian, Elisa Gouvea .
LIFE-BASEL, 2025, 15 (05)
[10]   Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis [J].
Abdul-Aziz, Mohd H. ;
Sulaiman, Helmi ;
Mat-Nor, Mohd-Basri ;
Rai, Vineya ;
Wong, Kang K. ;
Hasan, Mohd S. ;
Abd Rahman, Azrin N. ;
Jamal, Janattul A. ;
Wallis, Steven C. ;
Lipman, Jeffrey ;
Staatz, Christine E. ;
Roberts, Jason A. .
INTENSIVE CARE MEDICINE, 2016, 42 (10) :1535-1545
12345